April 5th 2025
The authors examine the risks of extractables and leachables, and present solutions that emphasize the importance of a strategic, multi-prong approach.
There is a great need for sensitive, precise, and easily accessible analytical detection techniques for protein sequencing.
GMPs for Method Validation in Early Development: An Industry Perspective (Part II)
August 1st 2012The authors, part of the International Consortium on Innovation and Quality in Pharmaceutical Development (IQ Consortium), explore and define common industry approaches and practices when applying GMPs in early development.
Product Neutralization for Rapid Microbiological Test Methods
July 18th 2012We have developed an in-house broth to neutralize a preservative for traditional microbiological testing following USP <61> Microbiological Examination of Non-Sterile Products: Microbial Enumeration Tests. We would like to use a rapid method to release product faster, but is there a broth that will be effective on our products?
GMPs for Method Validation in Early Development: An Industry Perspective (Part II)
IQ Consortium representatives explore industry approaches for applying GMPs in early development.
Evaluating Impurities in Drugs (Part III of III)
April 2nd 2012In Part III of a three-part article, the authors examine various degradation routes of APIs, impurities arising from interactions in formulations, metabolite impurities, various analytical methods to measure impuritie, and ways to control impurities.